INVO Fertility, Inc. (IVF): Nasdaq/NYSE listing notice — INVO gets Nasdaq extension until May 22, 2023 to regain compliance with equity rule

INVO Fertility, Inc.

Received Nasdaq deficiency notice on Nov 23, 2022 for stockholders' equity of $1.287M vs $2.5M minimum.
Submitted compliance plan; Nasdaq granted extension until May 22, 2023 on Jan 18, 2023.
Must file a publicly available report describing the transaction that enables compliance.
If not compliant by June 30, 2023 filing, Nasdaq may delist; company can appeal to Hearings Panel.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

(the “Stockholders’ Equity Requirement). In the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, the Company reported stockholders’ equity of $1,287,224, which is below the Stockholders’ Equity Requirement for continued listing. Additionally, as of the date of the Notice, the Company did not meet either of the alternative Nasdaq

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INVO Fertility, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5550(b)

Exact text from the filing

January 18, 2023 letter from Nasdaq granting an extension of time to regain compliance with Nasdaq Listing Rule 5550(b) until May 22, 2023. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 23, 2022, INVO Bioscience, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on

View on SEC.gov

Browse all listing & compliance notices →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-002209

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.